Odyssey Therapeutics, Inc. (ODTX) Insider Trading Disclosures
Odyssey Therapeutics, Inc. (ODTX) is a publicly traded company on the Nasdaq, categorized under SIC 2836 (Biological Products, (No Diagnostic Substances)). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: ODTX
CIK: 1882782
Exchange: Nasdaq
SIC 2836: Biological Products, (No Diagnostic Substances)
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Deloitte & Touche LLP
Auditor SinceSince 12/31/2023 12:00:00 AM
Lead Engagement PartnerMichelle Marseglia
Audit LocationBoston, Massachusetts, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-09-09 | 2026-09-08 | 8-K | 0001193125-26-385477 | View SEC Doc Filr Page |
| 10-Q | 2026-08-06 | 2026-06-30 | 10-Q | 0001193125-26-335822 | View SEC Doc Filr Page |
| 8-K | 2026-08-04 | 2026-08-04 | 8-K | 0001193125-26-331512 | View SEC Doc Filr Page |
| 8-K | 2026-06-23 | 2026-06-23 | 8-K | 0001193125-26-278581 | View SEC Doc Filr Page |
| 10-Q | 2026-06-17 | 2026-03-31 | 10-Q | 0001193125-26-274290 | View SEC Doc Filr Page |
| 8-K | 2026-06-17 | 2026-06-17 | 8-K | 0001193125-26-274291 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-06-05 | — | SCHEDULE 13G Filing | 0000315066-26-001419 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-05-18 | — | SCHEDULE 13G Filing | 0002044377-26-000002 | View SEC Doc Filr Page |
| SCHEDULE 13D | 2026-05-18 | — | SCHEDULE 13D Filing | 0001072613-26-000468 | View SEC Doc Filr Page |
| SCHEDULE 13D | 2026-05-18 | — | SCHEDULE 13D Filing | 0001999371-26-011002 | View SEC Doc Filr Page |
| SCHEDULE 13D | 2026-05-15 | — | SCHEDULE 13D Filing | 0001193125-26-226695 | View SEC Doc Filr Page |
| SCHEDULE 13D | 2026-05-15 | — | SCHEDULE 13D Filing | 0000950103-26-007273 | View SEC Doc Filr Page |
| 4 | 2026-05-13 | 2026-05-11 | FORM 4 | 0001999371-26-010652 | View SEC Doc Filr Page |
| 4 | 2026-05-12 | 2026-05-08 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001012975-26-000417 | View SEC Doc Filr Page |
| 3 | 2026-05-12 | 2026-05-07 | INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES | 0001012975-26-000416 | View SEC Doc Filr Page |
| 4 | 2026-05-11 | 2026-05-11 | 4 | 0001193125-26-217656 | View SEC Doc Filr Page |
| 4 | 2026-05-11 | 2026-05-07 | 4 | 0001193125-26-217607 | View SEC Doc Filr Page |
| 4 | 2026-05-11 | 2026-05-08 | 4 | 0001193125-26-217600 | View SEC Doc Filr Page |
| 4 | 2026-05-11 | 2026-05-11 | 4 | 0001193125-26-217593 | View SEC Doc Filr Page |
| 4 | 2026-05-11 | 2026-05-07 | 4 | 0001193125-26-217592 | View SEC Doc Filr Page |
| 4 | 2026-05-11 | 2026-05-07 | 4 | 0001193125-26-217590 | View SEC Doc Filr Page |
| 4 | 2026-05-11 | 2026-05-11 | 4 | 0001193125-26-217589 | View SEC Doc Filr Page |
| 4 | 2026-05-11 | 2026-05-07 | 4 | 0001193125-26-217588 | View SEC Doc Filr Page |
| 4 | 2026-05-11 | 2026-05-07 | 4 | 0001193125-26-217587 | View SEC Doc Filr Page |
| 4 | 2026-05-11 | 2026-05-07 | 4 | 0001193125-26-217586 | View SEC Doc Filr Page |